Mr. Ilan Sobel reports

BIOHARVEST SCIENCES TO HOST VIRTUAL SHAREHOLDER PRESENTATION SEPTEMBER 6, 2023

Bioharvest Sciences Inc. will host its Q2 performance update presentation on Wednesday, Sept. 6, 2023, at 11:30 a.m. PST (2:30 p.m. EST). The interactive session will be hosted by chief executive officer Ilan Sobel.

Mr. Sobel will discuss the Q2 financials to be released on Aug. 30, 2023, and he will provide additional information regarding major Vinia marketing programs and coming new product pipeline. Following the presentation, there will be a live question-and-answer session. All media and investors are invited to preregister. For any questions regarding the event, please contact info@bioharvest.com.

"I look forward to meeting with our shareholder partners on Sept. 6 and to sharing my enthusiasm about the prospects of Bioharvest and the achievements being made," stated Mr. Sobel. "I will shed some more light on the Q2 results scheduled to be released at the end of August, and I will offer an outlook into the key growth drivers of the company."

About Bioharvest Sciences Inc.

Bioharvest Sciences is a fast-growing biotech firm listed on the Canadian Securities Exchange. Bioharvest has developed a patented bio-cellgrowth platform technology capable of growing the active and beneficial ingredients in fruit and plants, at an industrial scale, without the need to grow the plant itself. Bioharvest is currently focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions, within two major business verticals -- nutraceutical health and wellness products such as dietary supplements and development of plant-cell-based active pharmaceutical ingredients (APIs) that focus on specific medical indications.

We seek Safe Harbor.